Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Use this KRYS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KRYS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KRYS SEC filings page. Lician reads the product cache first so this HTML stays unique to Krystal Biotech Inc even when a live quote feed is slow.
Latest cached year on this hub. Full KRYS income, balance, and cash tables.